Novartis

News

Novartis: No Comment on Market Rumors

Top-Feature

SCIEX

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Citrine

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Novartis

Novartis Still Seeking To Buy Out Alcon

Cutting Drug Prices Hampers New Development

Bayer Withdraws Patent Suit Against Teva

Big Pharma Stocks Could Rally in the Next Year

Russia To Spend $4 Billion On Pharma Industry By 2020

Bayer Sues Teva Over U.S. Launch Of Contraceptive

Pfizer Selling China Swine Vaccine Unit to Harbin Pharma

Pfizer Exec Jumps Ship to Head AstraZeneca's R&D

Teva Tests Biosimilar Version of Roche's Rituxan

Drugmaker Novartis Loses U.S. Gender Bias Trial

Novartis Sticks To FY Goals As Q1 EPS Beats Forecast

Oracle Buying Drug Software Maker Phase Forward

Novartis Buys Generics Firm Oriel

Brenntag Gets Warm Reception On German Market Debut

Brenntag To Start Trading on Frankfurt Stock Exchange

Nanotech Robots Deliver Gene Therapy Through Blood

Study: Novartis Ex-CEO Vasella's Bonus Too High

Novartis: No Comment on Market Rumors

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Expert Insights

ADCs for Precision Cancer Therapy

Novartis

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Upcoming Virtual Events

Siemens Joins the Global Impact Coalition

Operationalizing AI in Polymer Development: How Syensqo Is Scaling Impact with the Citrine Platform

Expert Insights

Newsletter & e-edition